Targeting PI3K Remains Complex in Cancer Therapy

December 13, 2018
Lewis C. Cantley, PhD

Dr. Lewis Cantley discusses targeting the PI3K pathway in breast cancer and the importance of managing ambient insulin levels during therapy.

Dr. Lewis Cantley discusses targeting the PI3K pathway in breast cancer and the importance of managing ambient insulin levels during therapy.